Sarah Nathaniel

Icahn School of Medicine at Mount Sinai

Papers

2

Total Citations

39

H-Index

2

About

Dr. Sarah Nathaniel is a leading urologic anesthesiologist whose research focuses on the intersection of perioperative care and oncologic outcomes, particularly in bladder cancer surgery. Her most influential work challenges conventional anesthetic practices, demonstrating through a landmark retrospective analysis that the choice between total intravenous and volatile anesthesia may significantly influence bladder cancer recurrence after robot-assisted radical cystectomy—a study that has garnered 23 citations and sparked critical debate in the field. Dr. Nathaniel further advanced perioperative medicine by pioneering a nonopioid protocol for patients undergoing this complex procedure with intracorporeal urinary diversion, an innovation that has earned 16 citations for its role in reducing opioid-related complications while maintaining effective pain control. Her contributions are reshaping how anesthesiologists approach cancer surgery, emphasizing that anesthetic agents are not merely supportive but potentially therapeutic. Dr. Nathaniel’s work stands at the forefront of a paradigm shift, where the anesthesiologist’s choices are recognized as active determinants of long-term patient outcomes.

Research Focus

Key Achievements

2
H-Index
2
Papers
39
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Can anesthetics affect bladder cancer recurrence? Total intravenous versus volatile anesthesia in patients undergoing robot-assisted radical cystectomy: A single institution retrospective analysis
23 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago